A new study from the Scripps Translational Science Institute, published in the American Journal of Medicine, shows that iRhythm's Zio patch, a wireless adhesive heart monitor patch, detects more ...
iRhythm Technologies, maker of the Zio patch peel-and-stick heart monitor, has raised $17 million in a round led by Novo A/S, a Danish life sciences investment firm. Previous investor Norwest Venture ...
iRhythm Technologies IRTC recently announced initial research findings on the post-market, real-world performance of the Zio monitor, IRTC’s next-generation Zio long-term continuous monitoring (LTCM) ...
iRhythm is launching its next generation long-term ambulatory cardiac monitor in the U.S. The new Zio monitor is a prescription-only ECG monitor, which is an integral part of the Zio LTCM service. The ...
SAN FRANCISCO, Sept. 09, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced initial research findings on post-market, real-world performance of Zio® monitor, its ...
iRhythm Technologies today unveiled initial findings on the post-market and real-world performance of its Zio monitor, building on the devices previous generation of the long-term continuous ...
NASDAQ:MDGL: $1.2 billion (11.6% of AUM) NASDAQ:INSM: $842.9 million (8.4% of AUM) NASDAQ:PTCT: $588.4 million (5.9% of AUM) NASDAQ:ARGX: $566.4 million (5.7% of AUM) NASDAQ:PTGX: $441.9 million (4.4% ...
The market has left medical device stocks in the dust, but heart monitor maker iRhythm Technologies is proving an exception. As doctors and hospitals slap its Zio patch monitors on more patients, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results